BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18803156)

  • 1. [Galantamine therapy in dementia associated with CADASIL].
    Posada IJ; Ferrero M; Lopez-Valdes E; Goni-Imizcoz M
    Rev Neurol; 2008 Sep 16-30; 47(6):299-300. PubMed ID: 18803156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.
    Aarsland D; Hutchinson M; Larsen JP
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):937-41. PubMed ID: 14533126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience of galantamine in dementia: a series of case reports.
    Dale MC; Libretto SE; Patterson C; Anderson J; Choudhury T; McCafferty F; McWilliam C; Richardson M
    Curr Med Res Opin; 2003; 19(6):508-18. PubMed ID: 14594523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
    Edwards K; Royall D; Hershey L; Lichter D; Hake A; Farlow M; Pasquier F; Johnson S
    Dement Geriatr Cogn Disord; 2007; 23(6):401-5. PubMed ID: 17409748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) presenting with sudden sensorineural hearing loss.
    Phillips JS; King JA; Chandran S; Prinsley PR; Dick D
    J Laryngol Otol; 2005 Feb; 119(2):148-51. PubMed ID: 15829071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newest developments in dementia treatment and prevention.
    Miller CA
    Geriatr Nurs; 2001; 22(4):216, 218. PubMed ID: 11505251
    [No Abstract]   [Full Text] [Related]  

  • 7. Galantamine in frontotemporal dementia and primary progressive aphasia.
    Kertesz A; Morlog D; Light M; Blair M; Davidson W; Jesso S; Brashear R
    Dement Geriatr Cogn Disord; 2008; 25(2):178-85. PubMed ID: 18196898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galantamine treatment of cognitive impairment in bipolar disorder: four cases.
    Schrauwen E; Ghaemi SN
    Bipolar Disord; 2006 Apr; 8(2):196-9. PubMed ID: 16542191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case with cholinesterase inhibitor responsive asymmetric posterior cortical atrophy.
    Kim E; Lee Y; Lee J; Han SH
    Clin Neurol Neurosurg; 2005 Dec; 108(1):97-101. PubMed ID: 16311158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
    Schwalbe O; Wunderlich S; Kloft C
    Med Monatsschr Pharm; 2006 Jun; 29(6):222-4. PubMed ID: 16792199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.
    Griffith HR; Martin R; Andrews S; LeBron Paige A; Ware J; Faught E; Welty T
    Epilepsy Behav; 2008 Aug; 13(2):376-80. PubMed ID: 18556248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of galantamine to treat vascular dementia.
    Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
    Lancet; 2002 Nov; 360(9344):1512-3; author reply 1513. PubMed ID: 12433549
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracerebral haemorrhage in CADASIL. A case report.
    Werbrouck BF; De Bleecker JL
    Acta Neurol Belg; 2006 Dec; 106(4):219-21. PubMed ID: 17323840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apathy: a major symptom in CADASIL.
    Reyes S; Viswanathan A; Godin O; Dufouil C; Benisty S; Hernandez K; Kurtz A; Jouvent E; O'Sullivan M; Czernecki V; Bousser MG; Dichgans M; Chabriat H
    Neurology; 2009 Mar; 72(10):905-10. PubMed ID: 19273824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebral hemorrhages in CADASIL.
    Choi JC; Kang SY; Kang JH; Park JK
    Neurology; 2006 Dec; 67(11):2042-4. PubMed ID: 17135568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Japanese CADASIL case with limited dementia who had the Notch 3 R141C mutation].
    Ishibashi K; Murata T; Miki Y; Hara M; Mori H
    No To Shinkei; 2005 May; 57(5):415-8. PubMed ID: 15981641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Galantamine].
    TaƩron C
    Rev Infirm; 2008 Sep; (143):44-6. PubMed ID: 18788671
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive decline and treatment options for patients with vascular dementia.
    Erkinjuntti T
    Acta Neurol Scand Suppl; 2002; 178():15-8. PubMed ID: 12492787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple teeth extractions in a patient with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), treated with ticlopidine.
    Maman L; Stieltjes N; Galeazzi JM; Kalafat M; Alantar A
    J Oral Maxillofac Surg; 2006 Jan; 64(1):127-9. PubMed ID: 16360869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.